REUTERS: Allergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage studies.
The trials evaluated the efficacy, safety and tolerability of Allergan's treatment, rapastinel, compared to a placebo, both in combination with antidepressant therapy in patients with depression who had a partial response to ADT, the company said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
ImmunoGen's ovarian cancer drug fails in late-stage studyREUTERS: U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Alnylam's gene-silencing drug meets main goal in late-stage studyREUTERS: Alnylam Pharmaceuticals Inc said on Wednesday its gene-silencing drug for treating a rare, painful disease met the main goal in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Vaginal laser treatment tied to complications like scarring(Reuters Health) - Vaginal laser treatments may help relieve problems associated with menopause, like dryness, pain and sexual dysfunction, but ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Trump to drop preferential trade treatment for India; Delhi plays down impactU.S. President Donald Trump looked set to open a new front in his trade wars on Monday with a plan to end preferential trade treatment for India ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Australia to send 57 refugees deemed a threat to island detention site for treatmentSYDNEY: Fifty-seven male asylum seekers deemed to be a security risk will be sent to a remote Pacific island detention centre for medical ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Trump to end special trade treatment for IndiaWASHINGTON/NEW DELHI US President Donald Trump looked set to open a new front in his trade wars on Monday with a plan to end preferential trade treatment for India that allows duty-free entry for up to US$5.6 billion (S$7.6 billion) worth of its exports to the US. India...
Source: thenewpaper - 🏆 7. / 63 Read more »
Ebola treatment center in Congo reopens after attack: ministryKINSHASA: An Ebola treatment center at the epicenter of the current outbreak in eastern Democratic Republic of Congo has resumed operations after ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »